Vaccine Licensure

Legislation and/or Policy Statements

IOM Reports on Vaccine Safety


Pneumococcal vaccine for infants and young children licensed (Prevnar)

ACIP recommends pneumococcal vaccination for all children 2–23 months, and at-risk children 24–59 months (e.g., immunocompromised)




October: ACIP drafts statement expressing a preference for use of thimerosal-free DtaP, Hib, and Hep B vaccines by March 2002

Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism

Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement